Alzheimer's

News

Closeup of X-ray photography of human brain

Eisai forges CNS alliance with UK’s Wren Therapeutics

Japanese drugmaker Eisai has teamed up with UK biotech Wren Therapeutics on an R&D programme seeking drugs for neurodegenerative disorders.

News

China's Green Valley prepares US trial of Alzheimer's drug i...

As an influential panel of FDA-appointed experts prepares its verdict on Biogen’s Alzheimer’s drug, a little known China-based pharma is hoping to succeed where big name rivals have failed

News

Biogen's shares surge again as FDA hurries Alzheimer's drug ...

Biogen’s Alzheimer’s drug aducanumab could be on the market in the next few months after the FDA accepted a clinical trial dossier and granted a fast Priority Review.

News

Biogen and Eisai trial drug in asymptomatic Alzheimer's dise...

Biogen and Eisai have begun a new phase 3 study testing an Alzheimer’s antibody drug aimed at patients without symptoms but with elevated levels of amyloid in their brains, the protein aggr

News

Biogen shares pop as it completes filing for Alzheimer's dru...

Biogen’s share price was up sharply on Wednesday after the big pharma completed its filing of its Alzheimer’s Disease (AD) drug aducanumab with the FDA.

News

FDA clears US trials of Green Valley's Alzheimer's drug

China’s Shanghai Green Valley Pharmaceuticals has clearance to begin a late stage clinical trial to support a US filing of its potential Alzheimer’s drug.

Eisai forges CNS alliance with UK’s Wren Therapeutics

China's Green Valley prepares US trial of Alzheimer's drug i...

Biogen's shares surge again as FDA hurries Alzheimer's drug ...

Biogen and Eisai trial drug in asymptomatic Alzheimer's dise...

Biogen shares pop as it completes filing for Alzheimer's dru...

FDA clears US trials of Green Valley's Alzheimer's drug

AI specialists Enveda and Basecamp rake in the cash

Discover a new era of healthcare panel engagement: Grounded ...

Alzheimer's

Editor's Picks